Myonexus Therapeutics - Innovate New Albany
Menu

Myonexus Therapeutics

Myonexus Therapeutics is a clinical stage gene therapy company developing first ever treatments for Limb-girdle muscular dystrophy (LGMD) types 2D, 2B, 2E, 2L, and 2C based on research at Nationwide Children’s Hospital, a leader in muscular dystrophy gene therapy discovery and translational research.

Expert Office Hours

Your Questions • Our Experts
Private Appointments

Fridays, 8:30-11:30 am

2023

February 3 August 4
April 7 October 6
June 2 December 7
(Thursday)

Have Expertise?

Share it

Subscribe to Our Updates!

  • Please enter your email address
  • This field is for validation purposes and should be left unchanged.

Why New Albany?

As a community created by innovators for innovators, New Albany offers a robust ecosystem that leverages entrepreneurship, business connectivity, public-private partnerships and quality of life to inspire creativity and accelerate commerce.

Learn More